Atlas Trials

Genexine, Inc.

36 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Genexine, Inc.

RecordFirmDate
Clinical Trial of Efepoetin Alfa in Healthy Subjects (NCT06490939)Genexine, Inc.2024-10-29
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis (NCT06466785)Genexine, Inc.2024-01-25
GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients (NCT05191784)Genexine, Inc.2022-01-26
Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines (NCT05067946)Genexine, Inc.2021-10-01
Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19 (NCT04730427)Genexine, Inc.2021-03-24
Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals (NCT04915989)Genexine, Inc.2021-02-16
Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults (NCT04715997)Genexine, Inc.2020-12-30
Safety and Tolerability of GX-P1 in Healthy Male Volunteers (NCT04298749)Genexine, Inc.2020-08-11
Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults (NCT04445389)Genexine, Inc.2020-06-17
Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma (NCT04065087)Genexine, Inc.2019-08-22
A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus (NCT03962010)Genexine, Inc.2019-06-01
Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899) (NCT03752723)Genexine, Inc.2019-03-27
GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors (NCT03733587)Genexine, Inc.2018-10-17
Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma (NCT03619239)Genexine, Inc.2018-06-20
The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer (NCT03444376)Genexine, Inc.2018-06-19
Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT03478995)Genexine, Inc.2018-03-05
Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients (NCT03276988)Genexine, Inc.2017-09-07

Track Genexine, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.